Clinical TrialID 6147

The Impact of Omega-3 Fatty Acid Supplements on Fibromyalgia Symptoms

NCT01352013

Fibromyalgia

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
6147
Evidence Id
6147
Core Evidence Id
6147
Source Clinical Trial Id
6132
Herb2 Clinical Trial Id
HBCT006132
Nct Id
NCT01352013
Title
The Impact of Omega-3 Fatty Acid Supplements on Fibromyalgia Symptoms
Status
Completed
Phase
Phase 2
Study Result
No
Study Condition
Fibromyalgia
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Intervention
DIETARY_SUPPLEMENT: Omega-3 (oil)|DIETARY_SUPPLEMENT: Fatty Acids (placebo)
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Treatment
Gender
Female
Age
Adult, Older_Adult
Enrollment
19
Outcome Measure
Visual analog scale (VAS), Pain intensity, 2 months
Sponsor Collaborator
Dr. Yoram Shir|McGill University
Funded By
OTHER
Location
Montreal General Hospital - Alan Edwards Pain Management Unit, Montreal, Quebec, H3G 1A4, Canada
Other Id
Omega3-MGH
Start Date
2012-01
Primary Completion Date
2013-09
Completion Date
2013-12
First Posted
2011-05-11
Results First Posted
Last Update Posted
2015-04-16
Study Document
Study Url
https://clinicaltrials.gov/study/NCT01352013
Title Cn
Title En
The Impact of Omega-3 Fatty Acid Supplements on Fibromyalgia Symptoms
Bilingual Status
semi_complete